Get notified of page updates

Pancreatic cancer screening for people at high risk and with an inherited BRCA1, BRCA2, ATM, or PALB2 mutation

Clinicaltrials.gov identifier:
NCT02478892

Study Contact Information:

   

PRINTER FRIENDLY PAGE

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients with an Inherited Genetic Risk Due to a BRCA1, BRCA2, PALB2 or ATM Mutation

Pancreatic cancer screening for people at high risk and with an inherited BRCA1, BRCA2, ATM, or PALB2 mutation

Clinicaltrials.gov identifier:
NCT02478892

Study Contact Information:

   

PRINTER FRIENDLY PAGE
Overview
Who Can Join
Contact
Glossary on
off

About this Study

NOTE: This Study is no longer recruiting patients. 

Improved screening for pancreatic cancer in high-risk groups, such as people with an inherited , , , or mutation, may help find cancer early and improve survival rates. People enrolled in this study will undergo screening using endoscopic or of the abdomen.

 

 

This Study is Open To:

NOTE: This Study is no longer recruiting patients.

This Study is NOT Open To:

NOTE: This Study is no longer recruiting patients.

Study Contact Information: